STUELPNAGEL JOHN R
SEC CIK 1189140 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | Dir | 328.4K | — | $12.74M | 20 | 2021-07-01 | 2026-09-03 |
Most active insiders at TXG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Saxonov Serge | CEO, Dir | — | $6.82M |
| 2 | Taich Adam | CFO | — | $4.84M |
| 3 | STUELPNAGEL JOHN R | Dir | — | $2.39M |
| 4 | Hindson Benjamin J. | See Remarks, Dir | — | $1.46M |
| 5 | SULIMAN SHEHNAAZ | Dir | — | $791.9K |
| 6 | Teichmann Sarah A. | Dir | — | $579.4K |
| 7 | Kosaraju Sridhar | Dir | — | — |
| 8 | MATEO ALAN | Dir | — | — |
| 9 | Popovits Kimberly J | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-08 19:00 | 2026-09-03 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $61.75 | -20.0K | 328.4K | -6% | -$1.24M |
| M | 2026-08-13 16:11 | 2026-08-11 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $57.75 | -20.0K | 348.4K | -5% | -$1.16M |
| 2026-06-08 19:26 | 2026-06-04 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | A - Grant | $0.00 | +8,829 | 368.4K | +2% | $0 | |
| 2025-06-05 | 2025-06-03 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | A - Grant | $0.00 | +15.4K | 359.6K | +4% | $0 | |
| 2024-06-13 | 2024-06-11 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | A - Grant | $0.00 | +8,649 | 344.2K | +3% | $0 | |
| D | 2023-06-16 | 2023-06-14 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | A - Grant | $0.00 | +1,865 | 335.6K | +0.6% | $0 |
| 2023-06-07 | 2023-06-05 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $54.89 | -10.0K | 333.7K | -3% | -$548.9K | |
| D | 2022-06-17 | 2022-06-15 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | A - Grant | $0.00 | +2,120 | 343.7K | +0.6% | $0 |
| M | 2022-01-04 | 2021-12-30 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $150.92 | -5,000 | 341.6K | -1% | -$754.6K |
| M | 2021-12-03 | 2021-12-01 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $151.16 | -5,000 | 349.6K | -1% | -$755.8K |
| M | 2021-11-18 | 2021-11-16 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $158.83 | -5,000 | 352.8K | -1% | -$794.2K |
| M | 2021-11-03 | 2021-11-01 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $163.51 | -5,000 | 361.5K | -1% | -$817.6K |
| M | 2021-10-20 | 2021-10-18 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $150.67 | -5,000 | 361.9K | -1% | -$753.3K |
| 2021-10-12 | 2021-10-07 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $150.18 | -5,000 | 366.6K | -1% | -$750.9K | |
| M | 2021-09-20 | 2021-09-16 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $156.33 | -5,000 | 374.4K | -1% | -$781.7K |
| M | 2021-09-03 | 2021-09-01 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $177.48 | -5,000 | 381.3K | -1% | -$887.4K |
| M | 2021-08-18 | 2021-08-16 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $159.56 | -5,000 | 385.0K | -1% | -$797.8K |
| M | 2021-08-04 | 2021-08-02 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $180.42 | -5,000 | 390.5K | -1% | -$902.1K |
| M | 2021-07-20 | 2021-07-16 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $170.31 | -5,000 | 391.6K | -1% | -$851.5K |
| M | 2021-07-06 | 2021-07-01 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Dir | S - Sale | $191.64 | -5,000 | 396.6K | -1% | -$958.2K |
Purchase Sale Sale after option exercise All abbreviations